The honest answer is: some do, most don't, and the difference between them is not what the labels suggest.
That's not a satisfying answer if you're looking for a simple yes or no. But it's the accurate one — and understanding why it's accurate is more useful than a blanket endorsement or dismissal of the entire category.
The sleep supplement market is large, loosely regulated, and heavily incentivised to overclaim. Most products in it are built around ingredients with limited evidence, at doses too low to produce meaningful physiological effects, in forms the body cannot efficiently absorb. The fact that some people report improvement from these products is real — but placebo effects in sleep research are among the strongest in any clinical area, which means subjective improvement is a poor proxy for whether a supplement is actually doing what it claims.
So let's be specific about what works, what doesn't, and what the criteria should be for telling the difference.
Why Most Sleep Supplements Fail
Before examining individual ingredients, the structural problem with most sleep supplements is worth naming.
Sleep is not a single mechanism. It is a system — governed by GABA signalling, cortisol rhythms, circadian timing, gut-brain axis chemistry, core body temperature regulation, and adenosine accumulation, among other variables. A supplement that addresses one of those mechanisms while leaving the others unmanaged is a partial intervention at best.
Most sleep supplements are built around a single active ingredient — typically melatonin — at a dose chosen for label appeal rather than physiological relevance. They address, at most, one mechanism. They are often in forms with poor bioavailability, which means the physiological dose reaching target tissues is a fraction of what the label suggests. And they are frequently evaluated over timescales — a few days or a week — that are insufficient for ingredients working through slower biological pathways to produce measurable effect.
The result is a category where most products are genuinely ineffective for most users, a subset of products work for specific sleep problems in specific people, and the marketing environment makes it nearly impossible for consumers to distinguish between them.
The Supplement That Dominates — And Its Limitations
Melatonin is the world's best-selling sleep supplement. In the United States it is classified as a dietary supplement rather than a hormone — an anomaly that doesn't exist in most other countries, where it requires a prescription — which has made it cheap, accessible, and ubiquitously marketed.
The evidence for melatonin is real but narrow. It is a timing signal — it governs when the body initiates sleep, not the quality or depth of sleep that follows. For specific applications — jet lag, shift work, delayed sleep phase syndrome — melatonin has genuine, evidence-supported utility. It resets the circadian clock efficiently and with a well-understood mechanism.
For the far more common sleep complaint — falling asleep adequately but sleeping shallowly, waking unrested, recovering poorly — melatonin addresses none of the underlying mechanisms. It moves the clock. It does not change what happens once the clock has moved.
Compounding this, the doses in standard supplements — typically 3 to 10mg — are ten to fifty times the physiological amount the pineal gland produces. Research from MIT's clinical research division found that doses of 0.3mg are as effective for sleep timing as higher doses, with lower supraphysiological hormonal load. At high doses, exogenous melatonin has been shown to suppress REM sleep duration in a proportion of users — reducing the quality of the sleep it's supposed to improve.
Melatonin, used appropriately at low doses for circadian disruption, works. Used nightly at standard supplement doses as a recovery tool, the evidence does not support the widespread use, and the REM suppression mechanism argues actively against it for anyone prioritising sleep quality over sleep onset.
What the Evidence Actually Supports
Moving through the supplement landscape by mechanism rather than by marketing category produces a more useful picture.
Magnesium — Evidence Strong, Form Critical
Magnesium's role in sleep is mechanistically specific and well-documented. It supports GABA receptor activity — the primary inhibitory neurotransmitter system that facilitates the transition from wakefulness into deep sleep. Adequate magnesium status also supports HPA axis regulation, contributing to appropriate evening cortisol decline.
The evidence base is substantial. Research from institutions including the University of Vermont has found significant proportions of adults — particularly those under stress or in high-output lifestyles — falling below optimal magnesium intake. Deficiency correlates with lighter, more fragmented sleep and higher nocturnal cortisol. Correction of deficiency through supplementation supports sleep quality improvement over four to six weeks of consistent use.
The critical variable is form. Magnesium oxide — the form in most budget supplements — has an absorption rate of approximately 4%. At that rate, a 300mg elemental magnesium supplement delivers roughly 12mg to tissues. Magnesium bisglycinate absorbs at substantially higher rates, crosses the blood-brain barrier efficiently, and is well-tolerated without gastrointestinal disruption. The ingredient works. The form determines whether it reaches the mechanism.
Ashwagandha — Evidence Growing, Mechanism Clear
Ashwagandha — specifically root extracts standardised for withanolide content — has an increasingly robust evidence base for cortisol regulation and downstream sleep quality improvement. Multiple randomised controlled trials have found that consistent use over eight to twelve weeks produces measurable reductions in serum cortisol in adults under chronic stress, with corresponding improvements in sleep quality scores.
The mechanism runs through the HPA axis — ashwagandha supports the regulatory system that governs cortisol output, helping the cortisol curve decline appropriately in the evening. Since elevated evening cortisol is one of the most common causes of poor deep sleep and early morning waking in high-output adults, this is a clinically relevant mechanism for the target population.
The important caveat: ashwagandha is not an acute intervention. The cortisol effects accumulate over weeks. A single dose does nothing measurable. This is why most people who try it for a week and notice nothing are drawing the wrong conclusion from the right experiment.
Probiotics and Prebiotics — Emerging Evidence, Important Mechanism
The gut-sleep axis is an increasingly documented biological pathway. Approximately 90 percent of the body's serotonin — the precursor to endogenous melatonin — is produced in the gut. Gut bacteria govern serotonin production. A compromised microbiome means compromised serotonin synthesis means impaired sleep-wake chemistry at the root level.
Probiotic and prebiotic supplementation supports microbiome diversity and function. The sleep effects are slower to manifest than magnesium or ashwagandha — microbiome shifts take weeks to months — but they address a mechanism that no single-ingredient sleep supplement touches. Research from institutions including the Karolinska Institute has documented associations between gut microbiome diversity and sleep quality in adult populations.
The evidence here is less mature than for magnesium or ashwagandha, but the mechanism is sound and the broader health benefits of microbiome support make it a rational inclusion in any nightly recovery formula regardless of the sleep-specific evidence.
Glycine — Underrated, Specific Mechanism
Glycine is an amino acid with a specific and well-documented effect on pre-sleep physiology. Research from Osaka City University found that glycine supplementation before sleep supports core body temperature reduction through peripheral vasodilation — one of the key physiological triggers for sleep onset and deep sleep maintenance.
The compound is not widely marketed as a sleep supplement despite having one of the cleaner mechanism-to-evidence chains in the category. It is found in collagen-rich foods and is also the compound that magnesium bisglycinate is bound to — meaning a well-formulated magnesium bisglycinate supplement delivers both the magnesium and the glycine in a single compound.
What Doesn't Have Meaningful Evidence
Several ingredients dominate sleep supplement marketing without meaningful evidence behind them at typical supplement doses.
Valerian root has been studied extensively with consistently inconsistent results — some trials show modest effects on sleep onset, others show no difference from placebo. The evidence does not support confident recommendations at any dose. Lavender aromatherapy has some evidence for subjective relaxation but no meaningful evidence for sleep architecture improvement. Passionflower has limited human trial data. 5-HTP has a plausible mechanism — it is a serotonin precursor — but the clinical evidence for sleep improvement specifically is thin and complicated by questions about long-term use.
None of these ingredients are dangerous at normal doses. None have evidence strong enough to be included in a recovery-focused formula based on mechanism alone.
The Standard the Category Should Be Held To
A sleep supplement that actually works needs to satisfy four criteria: it addresses a mechanism that is relevant to the user's specific sleep problem; it uses a form with demonstrated bioavailability; it is taken at a dose where the mechanism operates; and it is evaluated over a timeframe appropriate to the mechanism's speed of action.
Most products on the market fail at least two of those criteria. Many fail all four.
The supplement that addresses melatonin timing in someone with jet lag — melatonin at 0.3mg — works. The supplement that addresses GABA pathway support in someone with elevated cortisol and fragmented deep sleep — magnesium bisglycinate taken consistently over six weeks — works. The supplement that puts 500mg of magnesium oxide and 10mg of melatonin in a capsule and markets it as a sleep solution is doing very little for either mechanism.
Moongreens was built explicitly around the four criteria above. Albion® magnesium bisglycinate for GABA pathway and deep sleep support. KSM-66® ashwagandha for HPA axis and cortisol regulation. ProbioSEB® and Fibruline® for gut-sleep axis integrity. BioPerine® to maximise absorption of the full formula. No melatonin — because the people this formula is designed for don't have a timing problem. They have a recovery problem. Zero melatonin is not a marketing position. It is a mechanistic one. NSF Certified for Sport®. HSA/FSA eligible.
The Practical Takeaway
If you've tried a sleep supplement and it didn't work, the most likely explanations are: the ingredient didn't address your specific sleep problem, the form had poor bioavailability, the dose was insufficient, or you evaluated it over too short a timeframe.
None of those mean sleep supplements don't work. They mean that specific supplement didn't work for your specific problem. The category is not homogeneous — it contains both interventions with clear, documented mechanisms and products that are essentially expensive placebos. Telling them apart requires looking at mechanism, form, dose, and evidence quality rather than at packaging.
Do sleep supplements work? The honest answer is that the right ones, for the right problem, taken correctly and consistently, do. The market has just made it unreasonably difficult to find them.
The sleep supplement that works is the one built around your biology — not the one with the most convincing packaging.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.